darren moore foxo4-dri Mr. (51) from the USA tries the Youth Drug on himself! Darren Moore | Booking Agent

Martha M

Receptor-level pharmacology remains an active area of investigation

Subchronic and chronic toxicity studies extending up to several months of continuous BPC-157 administration reveal no significant organ toxicity, hematological abnormalities, or pathological changes in treated animals compared to controls

GLOW Blend is a research-grade three-peptide repair blend supplied in a single co-lyophilized vial GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg), 70 mg combined

Potential side effects are minimal in studies, but include mild gastrointestinal issues

Compounds like BPC-157, a fragment of a stomach protein that appears to accelerate tissue repair, were available through compounding pharmacies until the FDA restricted them in late 2023 under its Category 2 listing